S759 Efficacy and Safety of Mirikizumab in Patients With Ulcerative Colitis: 104-Week Results From a Phase 2 Randomized Controlled Trial. (October 2021)

Record Type:
Journal Article
Title:
S759 Efficacy and Safety of Mirikizumab in Patients With Ulcerative Colitis: 104-Week Results From a Phase 2 Randomized Controlled Trial. (October 2021)
Main Title:
S759 Efficacy and Safety of Mirikizumab in Patients With Ulcerative Colitis: 104-Week Results From a Phase 2 Randomized Controlled Trial
Authors:
Panaccione, Remo
Feagan, Brian G.
Redondo, Isabel
Lissoos, Trevor
Selinger, Christian
Arora, Vipin
Lukas, Milan
Matsuoka, Katsuyoshi
Hibi, Toshifumi
Abstract:
Is Part Of:
American journal of gastroenterology. Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1
Journal:
American journal of gastroenterology
Issue:
Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1
Issue Display:
Volume 116, Issue 1 (2021)
Year:
2021
Volume:
116
Issue:
1
Issue Sort Value:
2021-0116-0001-0000
Page Start:
S350
Page End:
S351
Publication Date:
2021-10
Subjects:
Stomach -- Diseases -- Periodicals
Intestines -- Diseases -- Periodicals
Gastroenterology -- Periodicals
Gastrointestinal Diseases -- Periodicals
Electronic journals
Periodicals
616.33
Journal URLs:
http://www.mdconsult.com/public/search?search_type=journal&j_sort=pub_date&j_date_range=1995-current&j_issn=0002-9270 ↗
http://www.amjgastro.com/ ↗
http://www.nature.com/ajg/archive/index.html ↗
http://www.sciencedirect.com/science/journal/00029270 ↗
http://www.nature.com/ ↗
http://www3.interscience.wiley.com/journal/117955841/home ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0002-9270;screen=info;ECOIP ↗
DOI:
10.14309/01.ajg.0000776568.90890.67 ↗
Languages:
English
ISSNs:
0002-9270
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 0824.650000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
19889.xml